Acifran

This classification denotes an anti-lipidemic agent with the molecular formula C12H10O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B1X701S0MV, chemically known as 4,5-dihydro-5-methyl-4-oxo-5-phenyl-2-furancarboxylic acid but generally known as acifran, which bears US NIH Compound Identifier 51576. European Medicines Agency schedules Acifran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05236MIG. The term ACIFRAN is an International Non-Proprietary Name. ACIFRAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acifran under HS 29321900 and SITC 51569. As of Q4 2014, ACIFRAN remains the US FDA Preferred Term for this commodity. Acifran bears US NLM identifiers UMLS ID C0052730 and NCI Concept Code C81534. SMILES: CC1(C(=O)C=C(O1)C(=O)O)C2=CC=CC=C2.